Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events

Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice

(2019) Anna Salazar-Degracia et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Expresión de PD-L1 en muestras de cáncer pulmonar no microcítico obtenidas por EBUS-TBNA

(2018) Sebastián Fernandez-Bussy et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death

(2018) Tsadik Habtetsion et al.   Cell Metabolism

Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway

(2018) Xuling Su et al.   Oxidative Medicine and Cellular Longevity

Expresión de PD-L1 en muestras de cáncer pulmonar no microcítico obtenidas por EBUS-TBNA

(2018) Sebastián Fernandez-Bussy et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions

(2018) Mercè Mateu-Jimenez et al.   Clinical Epigenetics

High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells

(2018) Rob J. W. Arts et al.   Frontiers in Immunology

Accurate Identification of Predictive Biomarkers of Response to Targeted Therapies in Lung Cancer With Next Generation Sequencing

(2018) Laura Moliner et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Immunotherapy is Here to Stay: A New Treatment Paradigm in Lung Cancer

(2018) Pedro Rocha et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype

(2017) Alba Chacon-Cabrera et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease

(2017) Mercè Mateu-Jimenez et al.   Journal of Thoracic Oncology

Elements of cancer immunity and the cancer–immune set point

(2017) Daniel S. Chen et al.   NATURE

Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable

(2017) Marc Miravitlles et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD

(2017) Claus F. Vogelmeier et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Macrophages, Inflammation, and Lung Cancer

(2016) Emma M. Conway et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Reduced tumor burden through increased oxidative stress in lung adenocarcinoma cells of PARP-1 and PARP-2 knockout mice

(2016) Mercè Mateu-Jiménez et al.   BIOCHIMIE

The Emerging Role of B Cells in Tumor Immunity

(2016) Peiling Tsou et al.   CANCER RESEARCH

Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer

(2016) Weimin Wang et al.   CELL

Pharmacological Approaches in an Experimental Model of Non-Small Cell Lung Cancer: Effects on Tumor Biology

(2016) Mercè Mateu-Jimenez et al.   CURRENT PHARMACEUTICAL DESIGN

Short- and Long-Term Hindlimb Immobilization and Reloading: Profile of Epigenetic Events in Gastrocnemius

(2016) Alba Chacon-Cabrera et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Redox Imbalance in Lung Cancer of Patients with Underlying Chronic Respiratory Conditions

(2016) Mercé Mateu-Jiménez et al.   MOLECULAR MEDICINE

Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights

(2016) Esther Barreiro et al.   Journal of Thoracic Disease

Inflammatory regulatory T cells in the microenvironments of ulcerative colitis and colon carcinoma

(2016) Ilona Kryczek et al.   OncoImmunology

MicroRNA expression and protein acetylation pattern in respiratory and limb muscles of Parp-1−/− and Parp-2−/− mice with lung cancer cachexia

(2015) Alba Chacon-Cabrera et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy

(2015) A. Yonezawa et al.   CLINICAL CANCER RESEARCH

Deacetylation of Nuclear LC3 Drives Autophagy Initiation under Starvation

(2015) Rui Huang et al.   MOLECULAR CELL

Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies

(2014) M. Dai et al.   CLINICAL CANCER RESEARCH

Therapeutic use of anti-CTLA-4 antibodies

(2014) C. U. Blank et al.   INTERNATIONAL IMMUNOLOGY

Pharmacological Strategies in Lung Cancer-Induced Cachexia: Effects on Muscle Proteolysis, Autophagy, Structure, and Weakness

(2014) Alba Chacon-Cabrera et al.   JOURNAL OF CELLULAR PHYSIOLOGY

PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma

(2014) Georg Karpel-Massler et al.   PLoS One

Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD

(2013) Esther Barreiro et al.   FREE RADICAL BIOLOGY AND MEDICINE

Oncology Meets Immunology: The Cancer-Immunity Cycle

(2013) Daniel S. Chen et al.   IMMUNITY

Long-lasting Complete Regression of Established Mouse Tumors by Counteracting Th2 Inflammation

(2013) Min Dai et al.   JOURNAL OF IMMUNOTHERAPY

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

(2013) M. J. Selby et al.   Cancer Immunology Research

Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines

(2011) Nupur N. Gangopadhyay et al.   CANCER INVESTIGATION

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Targeting apoptosis pathways in lung cancer

(2010) Milind M. Pore et al.   CANCER LETTERS

The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer

(2010) Dermot S. O'Callaghan et al.   Journal of Thoracic Oncology

Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes

(2009) T. J. Gaymes et al.   HAEMATOLOGICA